Surgery Partners' Buyout Leaves Little To Be Had By Holding On (Downgrade)
Surgery Partners surged 47.6% after agreeing to a $23.50/share buyout by HealthSpan Partners. Click for more on SGRY stock.
Archived explainer. For the current picture see today's SGRY page.
SURGERY PARTNERS INC (SGRY) is up +47.62% in the latest session. Our newswire has captured 35 stories on SGRY across 18 sources in the last 36 hours, with AI sentiment reading bullish (avg 63/100).
Surgery Partners (SGRY) shares surged 47.62% to $23.25 on Monday, October 26, 2026. The primary driver for the move is an agreement for the company to be acquired by HealthSpan Partners, a Bon Secours affiliate, in an all-cash transaction.
HealthSpan Partners agreed to buy the outpatient surgery center operator for $5.7 billion in cash, valuing shares at $23.50. The deal values the company at an enterprise value of approximately $5.7 billion. This acquisition will take the company private. In the immediate aftermath of the announcement, Cantor Fitzgerald downgraded the stock from Overweight to Neutral. Brodsky & Smith also issued a shareholder update notifying investors of ongoing investigations related to Surgery Partners, Range Resources, American Oncology Network, and Utz Brands.
The stock closed near the top of its 52-week range, which spans from $11.41 to $23.44. Over the last eight sessions, the stock moved up 57.4%, rising from $14.77 to $23.25. On the day of the announcement, the stock printed 13 fresh 52-week highs and 4 fresh 52-week lows. Fundamentals indicate the company has a market capitalization of $2.0 billion and is currently unprofitable, with a trailing twelve-month EPS of -0.69. Revenue grew 4.0% over the trailing twelve months, while the net margin stood at -2.6%. The stock carries a beta of 1.91. Recent insider activity shows two buys totaling $305,000 in the last 90 days, with no sells recorded. The most recent filing was dated August 20, 2026.
With the company moving to private ownership, the focus shifts to the completion of the $5.7 billion transaction. Investors will monitor the finalization of the deal terms and the subsequent delisting process from the Nasdaq.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
Surgery Partners surged 47.6% after agreeing to a $23.50/share buyout by HealthSpan Partners. Click for more on SGRY stock.
Surgery Partners stock soars as HealthSpan proposes a $5.7 billion takeover deal. But is it already too late to invest in SGRY shares? Let’s find out!
HealthSpan Partners agreed to buy the outpatient surgery center operator for $5.7 billion in cash, valuing shares at $23.50, today, Oct. 26, 2026.
BALA CYNWYD, Pa., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to...
Healthcare stocks were lower Monday afternoon, with the NYSE Healthcare Index down 0.1% and the State Street Health Care Select Sector SPDR ETF easing 0.3%. The iShares Biotechnology ETF added 0.1%. In corporate news, Surgery Partners (SGRY.NaE) has agreed to be acquired by HealthSpan Partners in an all-cash deal valued at an enterprise value of about $5.7 billion, the companies said Monday.
Surgery Partners (SGRY.NaE) said Monday it has agreed to be acquired by HealthSpan Partners in an all-cash deal valuing the company at an enterprise value of about $5.7 billion. Shares soared 47%, with intraday trading volume catapulting to over 51.0 million from a daily average of about 2.3 million.
Why Surgery Partners (SGRY) stock is trading up today
More on SGRY: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier SGRY move explainers: 2026-10-27 · 2026-09-01